| Title | Molecular Infectious Disease Testing Market worth $17.78 billion by 2029 |
|---|
| URL | https://www.marketsandmarkets.com/Market-Reports/molecular-infectious-disease-testing-market-40667482.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Molecular Infectious Disease Testing Market |
|---|
| Meta Description | Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, Flu, GI, HAI), Technology (PCR, NGS), End User (Diagnostic Labs, Hospitals) |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The molecular infectious disease testing market is expected to grow from USD 9.37 billion in 2024 to USD 17.78 billion by 2029, registering a CAGR of 13.7% during the forecast period. This growth is driven by the increasing prevalence of infectious diseases such as HIV, HPV, hepatitis, and CT/NG, as well as the emergence of novel pathogens that require rapid and accurate diagnosis. Rising investments in R&D are advancing molecular diagnostic technologies like PCR and NGS, improving test accuracy, speed, and multiplexing capabilities. Additionally, growing public and private funding, along with government initiatives to strengthen diagnostic infrastructure, is accelerating innovation and supporting the development of advanced molecular testing solutions to effectively address global infectious disease challenges. |
